French therapeutic ultrasound developer EDAP TMS has received the CE Mark for its Focal.One robotic high-intensity focused ultrasound (HIFU) device.
Focal.One is dedicated to focal therapy of prostate cancer, according to the vendor.
The CE Mark positions Focal.One for full commercialization in Europe and in many other countries, CEO Marc Oczachowski said in a statement.